APA

Bernhardt G., Gust R., Reile H., vom Orde H. D., Müller R., Keller C., Spruss T., Schönenberger H., Burgemeister T. & Mannschreck A. (19920417). [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. II. Synthesis and preliminary testing of the enantiomeric complexes. : Journal of cancer research and clinical oncology.

Chicago

Bernhardt G, Gust R, Reile H, vom Orde H D, Müller R, Keller C, Spruss T, Schönenberger H, Burgemeister T and Mannschreck A. 19920417. [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. II. Synthesis and preliminary testing of the enantiomeric complexes. : Journal of cancer research and clinical oncology.

Harvard

Bernhardt G., Gust R., Reile H., vom Orde H. D., Müller R., Keller C., Spruss T., Schönenberger H., Burgemeister T. and Mannschreck A. (19920417). [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. II. Synthesis and preliminary testing of the enantiomeric complexes. : Journal of cancer research and clinical oncology.

MLA

Bernhardt G, Gust R, Reile H, vom Orde H D, Müller R, Keller C, Spruss T, Schönenberger H, Burgemeister T and Mannschreck A. [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. II. Synthesis and preliminary testing of the enantiomeric complexes. : Journal of cancer research and clinical oncology. 19920417.